Issue Date: August 22, 2016 | Web Date: August 21, 2016
Agilent doubles down on oligonucleotides
Agilent Technologies plans to at least double its oligonucleotide manufacturing capacity with an expansion of its plant in Frederick, Colo. The project is expected to create between 150 and 200 jobs. The instrumentation firm began its foray into nucleic acids in 2006 with the acquisition of SynPro. In 2008, it purchased Dow Chemical’s oligonucleotides business and moved it from Michigan to Colorado.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society